Article Details
Retrieved on: 2022-12-24 08:23:06
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Vigil Neuroscience, Inc. (NASDAQ:VIGL - Get Rating) has been assigned a consensus recommendation of "Moderate Buy" from the six research firms ...
Article found on: www.marketbeat.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here